(District of Delaware). Represented DNA Genotek in litigation asserting patent involving DNA sample collection devices. Obtained eight-figure settlement and ongoing royalty following favorable IPR and claim construction proceedings.
(Central District of California). Represented several Alcon entities in patent litigation regarding femtosecond lasers for eye surgery. Prevailed on summary judgment that the three asserted patents were not infringed by the accused devices.
(District of Nevada). Represented Sandoz in Hatch-Waxman litigation regarding the company’s application to sell an injectable oncology drug. Of the 14 claims originally asserted by Spectrum against Sandoz’s proposed generic version of levoleucovorin, successfully eliminated all but two claims before trial. After a five-day bench trial, the court found clear and convincing evidence of obviousness and invalidated the remaining two claims.
Represented international corporations in a multi-year arbitration in connection with the operation of an open-pit mine. Obtained a favorable award for the clients, along with the rejection of the respondent’s counterclaims, and subsequently obtained confirmation and judgment on the entire award.
Represented communications companies in connection with patent litigation regarding television distribution and video services technology.
Represented a healthcare firm and certain of its officers and directors in connection with a shareholder action brought under the federal Securities Exchange Act and the Colorado Securities Act.
Represented members of a public company’s audit committee in connection with a Securities and Exchange Commission investigation regarding executive compensation.